Modulation of cholesterol metabolism by the green tea polyphenol (-)-epigallocatechin gallate in cultured human liver (HepG2) cells

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 5, 2006, Pages 1621-1626

  Bursill, Christina A ^a,b,c   Roach, Paul D ^c,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Catechins; Cholesterol; Cholesterol synthesis; Lathosterol; SREBP 1

Indexed keywords

CATECHIN; CHENODEOXYCHOLIC ACID; CHOLESTEROL; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; LANOSTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SREBF1 PROTEIN, HUMAN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; HUMAN; LIVER; METABOLISM; PLANT LEAF; TEA; TUMOR CELL LINE;

CAMELLIA SINENSIS; CATECHIN; CELL LINE, TUMOR; CHENODEOXYCHOLIC ACID; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LANOSTEROL; LIVER; PLANT LEAVES; RECEPTORS, LDL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ANIMALIA;

EID: 33645460618     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf051736o     Document Type: Article

References (40)

1. Kono, S.; Shinchi, K.; Wakabayashi, K.; Honjo, S.; Todoroki, I.; Sakurai, Y.; Imanishi, K.; Nishikawa, H.; Ogawa, S.; Katsurada, M. Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J. Epidemiol. 1996, 6, 128-133.
2. Imai, K.; Nakachi, K. Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. Br. Med. J. 1995, 310, 693-696.
3. Muramatsu, K.; Fukuyo, M.; Hara, Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J. Nutr. Sci. Vitaminol. 1986, 32, 613-622.
4. Matsuda, H.; Chisaka, T.; Kambomura, Y.; Yamahara, J.; Sawada, T.; Fujimura, H.; Kimura, H. Effects of crude drugs on experimental hypercholesterolemia. I. Tea and its active principles. J. Ethnopharmacol. 1986, 17, 213-224.
5. Yang, T. T.; Koo, M. W. Hypocholesterolemic effects of Chinese tea. Pharm. Res. 1997, 35, 505-512.
6. Fukuyo, M.; Hara, Y.; Muramatsu, K. Effect of tea leaf catechin, (-)-epigallocatechin gallate, on plasma cholesterol level in rats. J. Jpn. Soc. Nutr. Food Sci. 1986, 39, 495-500.
7. Chan, P. T.; Fong, W. P.; Cheung, Y. L.; Huang, Y.; Ho, W. K.; Chen, Z. Y. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J. Nutr. 1999, 129, 1094-1101.
8. Yang, T. T.; Koo, M. W. Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci. 2000, 66, 411-423.
9. Vinson, J. A.; Teufel, K.; Wu, N. Green and black teas inhibit atherosclerosis by lipid, antioxidant and fibrinolytic mechanisms. J. Agric. Food Chem. 2004, 52, 3661-3665.
10. Miua, Y.; Chiba, T.; Tomita, I.; Kiozuma, H.; Miura, S.; Umegaki, K.; Hara, Y.; Ikeda, M.; Tomita, T. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J. Nutr. 2001, 131, 27-32.
11. Graham, H. N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 1992, 21, 334-350.
12. Harbowy, M. E.; Balentine, D. A. Tea chemistry. Crit. Rev. Plant Sci. 1997, 16, 415-480.
13. Chisaka, T.; Matsuda, H.; Kubomura, Y.; Mochizuki, M.; Yamahara, J.; Fujimura, H. The effect of crude drugs on experimental hypercholesterolaemia: mode of action of (-)-epigallocatechin gallate in tea leaves. Chem. Pharm. Bull. 1988, 36, 227-233.
14. Chyu, K. Y.; Babbidge, S. M.; Zhao, X.; Dandillaya, R.; Rierveld, A. G.; Yano, J.; Dimayuga, P.; Cercek, B.; Shah, P. K. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 2004, 109, 2448-2453.
15. Brown, M. S.; Goldstein, J. A. A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232, 34-47.
16. Bursill, C.; Roach, P. D.; Bottema, C. D.; Pal, S. Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J. Agric. Food Chem. 2001, 49, 5639-5645.
17. Kuhn, D. J.; Burns, A. C.; Kazi, A.; Dou, Q. P. Direct inhibition of the ubiquitin-proteasome pathway by ester bond-containing green tea polyphenols is associated with the increased expression of sterol regulatory-binding protein 2 and LDL receptor. Biochim. Biophys. Acta 2004, 1682, 1-10.
18. Huang, M. T.; Ho, C. T.; Wang, Z. Y.; Ferraro, T.; Finnegan-Olive, T.; Lou, Y. R.; Mitchell, J. M.; Laskin, J. D.; Newmark, H.; Yang, C. S.; Conney, A. Inhibitory effect of topical application of a polyphenol fraction on tumour initiation and promotion in mouse skin. Carcinogenesis 1992, 13, 947-954.
19. Kambouris, A. M.; Roach, P. D.; Calvert, G. D.; Nestel, P. J. Retroendocytosis of high-density lipoproteins by the human hepatoma cell line, HepG2. Arteriosclerosis 1990, 10, 582-590.
20. Lowry, O. H.; Rosebrough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
21. Roach, P. D.; Hosking, J.; Clifton, P. M.; Bais, R.; Kusenic, B.; Coyle, P.; Wight, M. B.; Thomas, D. W.; Nestel, P. J. The effects of hypercholesterolaemia, simvastatin and dietary fat on the low-density lipoprotein receptor of unstimulated mononuclear cells. Atherosclerosis 1993, 103, 245-254.
22. Roach, P. D.; Balasubramaniam, S.; Hirata, F.; Abbey, M.; Szanto, A.; Simons, L. A.; Nestel, P. J. The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. Biochim. Biophys. Acta 1993, 1170, 165-172.
23. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-684.
24. Burnette, W. N. "Western Blotting": Electrophoretic transfer of proteins from sodium dodecyl sulphate - polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 1981, 112, 195-203.
25. Krika, L. J. Chemiluminescent and bioluminescent techniques. Clin. Chem. 1991, 37, 1472-1481.
26. Kempen, H. J.; Glatz, J. F.; Gevers Leuven, J. A.; van der Voort, H. A.; Katan, M. B. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J. Lipid Res. 1988, 29, 1149-1155.
27. Wolthers, B. J.; Walrecht, H. T.; van der Molen, J. C.; Nagel, G. T.; Van Doormaal, J. J.; Wijnandts, P. N. Use of determinants of 7-lathosterol (5α-cholest-7-en-3β-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis. J. Lipid Res. 1991, 32, 603-612.
28. Axelson, M.; Mörk, B.; Everson, G. T. Bile acid synthesis in cultured human hepatoblastoma cells. J. Biol. Chem. 1991, 266, 17770-17777.
29. Ross, P. E.; Pennington, C. R.; Bouchier, I. A. Gas - liquid chromatographic assay of serum bile acids. Anal. Biochem. 1977, 80, 458-465.
30. Wang, X.; Sato, R.; Brown, M. S.; Goldstein, J. L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 1994, 77, 53-62.
31. Brown, M. S.; Goldstein, J. L. Sterol regulatory element binding proteins (SREBPs): Controllers of lipid synthesis and cellular uptake. Nutr. Rev. 1998, 56, S1-S3.
32. Havekes, L. M.; De Wit, E. C.; Princen, H. M. Cellular free cholesterol in Hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity. Biochem. J. 1987, 247, 739-746.
33. Grundy, S. M. Multifactorial etiology of hypercholesterolaemia. Arterioscler. Thromb. 1991, 11, 1619-1635.
34. Winegar, D. A.; Salisbury, J. A.; Sundseth, S. S.; Hawke, R. L. Effects of cyclosporin on cholesterol 27-hydroxylation and LDL receptor activity in HepG2 cells. J. Lipid Res. 1996, 37, 179-191.
35. Brown, M. S.; Goldstein, J. L. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane bound transcription factor. Cell 1997, 89, 331-340.
36. Shimomura, I.; Shimano, H.; Horton, J. D.; Goldstein, J. L.; Brown, M. S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 1997, 99, 838-845.
37. Horton, J. D.; Goldstein, J. L.; Brown, M. S. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109, 1125-1131.
38. Abe, I.; Seki, T.; Umehara, K.; Miyase, T.; Noguchi, H.; Sakakibara, J.; Ono, T. Green tea polyphenols: Novel and potent inhibitors of squalene epoxidase. Biochem. Biophys. Res. Commun. 2000, 268, 767-771.
39. Ikeda, I.; Imasato, Y.; Sasaki, E.; Nakayama, M.; Nagao, H.; Takeo, T.; Yayabe, F.; Sugano, M. Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim. Biophys. Acta 1992, 1127, 141-146.
40. Yee, W. L.; Wang, Q.; Agdinaoay, T.; Dang, K.; Chang, H.; Grandinetti, A.; Franke, A. A.; Theriault, A. Green tea catechins decrease apolipoprotein B-100 secretion from HepG2 cells. Mol. Cell Biochem. 2002, 229, 85-92.